Screening of gastric cancer in Asia.

In North-Eastern Asian countries, where incidence and mortality of gastric cancer remain very high, population-based gastric cancer screenings have been conducted under governmental subsidy in Japan and Korea. Reduction of gastric cancer mortality by the screening was documented in Japan, but the Japanese gastric cancer screening with the X-ray photofluorography is criticized for its high cost and a low uptake rate. Although the Korean program seems to achieve a high-rate of uptake with increasing use of endoscopy, the work load is substantial. In the meantime, more attention in the world turns to primary prevention through eradication of Helicobacter pylori. Indeed, fairly large-scale studies to examine the feasibility of mass-eradication to prevent gastric cancer are underway in China and Taiwan. In the future, gastric cancer screening should incorporate 'screen to treat' of H. pylori infection at younger age followed by endoscopic surveillance for subjects at risk.

[1]  Manami Inoue,et al.  Gastric cancer screening and subsequent risk of gastric cancer: A large‐scale population‐based cohort study, with a 13‐year follow‐up in Japan , 2006, International journal of cancer.

[2]  K. Matsushita,et al.  Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis , 2011, Journal of Gastroenterology.

[3]  J. Tashiro,et al.  Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker , 2013, Gastric Cancer.

[4]  I. Choi,et al.  Performance of Different Gastric Cancer Screening Methods in Korea: A Population-Based Study , 2012, PloS one.

[5]  M. Gail,et al.  Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. , 2014, Journal of the National Cancer Institute.

[6]  S. Shirahama,et al.  Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital, Nagasaki Prefecture. , 2007, World journal of gastroenterology.

[7]  K. Miki Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.

[8]  Fang Wang,et al.  Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis , 2015, Scientific Reports.

[9]  N. Yoshimura,et al.  Gastric cancer screening of a high‐risk population in Japan using serum pepsinogen and barium digital radiography , 2005, Cancer science.

[10]  P. Malfertheiner,et al.  Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.

[11]  I. Choi,et al.  Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea , 2014, British Journal of Cancer.

[12]  Yuan Yuan A survey and evaluation of population-based screening for gastric cancer , 2013, Cancer biology & medicine.

[13]  M. Vieth,et al.  A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication , 2015, Gut.

[14]  M. Kodaira,et al.  Serum pepsinogens as an early diagnostic marker of H. pylori eradication. , 2008, Hepato-gastroenterology.

[15]  T. Chen,et al.  The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention , 2012, Gut.

[16]  Hossam Haick,et al.  Detection of precancerous gastric lesions and gastric cancer through exhaled breath , 2015, Gut.

[17]  Shengyong Fu,et al.  The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis , 2014, Clinical and Experimental Medicine.

[18]  Y. Sugisaki,et al.  Helicobacter pylori infection‐negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics , 2007, Cancer science.

[19]  M. Inoue,et al.  Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[20]  N. Yamamichi,et al.  Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer , 2014, International journal of cancer.

[21]  J. So,et al.  Endoscopic screening for gastric cancer. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  H. Tajiri,et al.  The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk , 2011, Journal of Gastroenterology.

[23]  K. Choi,et al.  Screening for Gastric Cancer in Korea: Population-Based Preferences for Endoscopy versus Upper Gastrointestinal Series , 2009, Cancer Epidemiology Biomarkers & Prevention.

[24]  Ming-Fang Yen,et al.  Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[25]  Y. Yamaji,et al.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study , 2005, Gut.

[26]  Wei-Chih Liao,et al.  Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions , 2013, BMJ Open.

[27]  M. Kaminishi,et al.  Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. , 2011, Gastroenterology.

[28]  R. Hunt,et al.  Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials , 2014, BMJ : British Medical Journal.

[29]  T. Azuma,et al.  Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis , 2010, Digestive Diseases and Sciences.

[30]  Anna Trakoli IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. International Agency for Research on Cancer , 2012 .

[31]  A. Tashiro,et al.  Comparing mass screening techniques for gastric cancer in Japan. , 2006, World journal of gastroenterology.

[32]  H. Yatsuya,et al.  Prospective study of screening for stomach cancer in Japan , 2003, International journal of cancer.

[33]  M A Fujino,et al.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations , 1999, Gut.

[34]  N. Naidoo,et al.  A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk , 2013, PloS one.

[35]  Khean Lee Goh,et al.  Screening for gastric cancer in Asia: current evidence and practice. , 2008, The Lancet. Oncology.

[36]  M. Gail,et al.  Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. , 2012, Journal of the National Cancer Institute.

[37]  K. Sugano,et al.  Clinical Management of Helicobacter pylori - The Japanese Perspective , 2014, Digestive Diseases.

[38]  D. Graham,et al.  Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations , 2016, Gut and liver.

[39]  K. Murakami,et al.  Tu1056 A Phase 3, Double-Blind Study of a Triple Therapy With TAK-438, Amoxicillin, and Clarithromycin As First Line Eradication of H. pylori and a Triple Therapy With TAK-438, Amoxicillin, and Metronidazole As Second Line Eradication of H. pylori , 2014 .

[40]  C. Crespi,et al.  Colorectal cancer among Koreans living in South Korea versus California: incidence, mortality, and screening rates , 2014, Ethnicity & health.

[41]  K. Miki Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method” , 2011, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[42]  M. Asaka,et al.  Recent development of gastric cancer prevention. , 2012, Japanese journal of clinical oncology.

[43]  Kazuhide Yamamoto,et al.  The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori , 2011, Journal of Gastroenterology.

[44]  C. Hamashima,et al.  A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan , 2013, PloS one.

[45]  K. Choi,et al.  Gastric Cancer Screening Uptake Trends in Korea: Results for the National Cancer Screening Program From 2002 to 2011 , 2015, Medicine.

[46]  K. Haruma,et al.  Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study , 2007, Scandinavian journal of gastroenterology.

[47]  Masakazu Hattori,et al.  Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry , 2008, Scandinavian journal of gastroenterology.

[48]  S. Menon,et al.  How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis , 2014, Endoscopy International Open.

[49]  J. Otaki,et al.  Prevalence of Helicobacter pylori infection with healthy subjects in Japan , 2014, Journal of gastroenterology and hepatology.

[50]  T. Itoi,et al.  Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan , 2007, Inflammopharmacology.

[51]  K. Choi,et al.  Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. , 2010, World journal of gastroenterology.

[52]  C. Hamashima Current issues and future perspectives of gastric cancer screening. , 2014, World journal of gastroenterology.

[53]  K. Murakami,et al.  Prevalence of Helicobacter pylori Infection by Birth Year and Geographic Area in Japan , 2014, Helicobacter.

[54]  T. Gotoda,et al.  Detection of early gastric cancer: misunderstanding the role of mass screening , 2006, Gastric Cancer.

[55]  Tomotaka Sobue,et al.  The Japanese guidelines for gastric cancer screening. , 2008, Japanese journal of clinical oncology.

[56]  K. Yao,et al.  New Diagnostic Approaches for Early Detection of Gastric Cancer , 2005, Digestive Diseases.